[#DIV28SUPER] Post-Doctoral Training Opportunities at the University of Chicago

Sending on behalf of Dr. Harriet de Wit:

Post-Doctoral Training Opportunities in Addiction 

NIDA T32 Training Grant 

http://voices.uchicago.edu/addictiont32/ 

 

Join a dynamic, multidisciplinary training program at the University of Chicago.  Our training program offers a wide range of opportunities in addiction research, from basic preclinical neuroscience to human behavior.  Trainees acquire a range of experiences within their primary research area as well as through externships in other areas.  Faculty research interests include cellular and molecular mechanisms (Xiaoxi Zhuang, Bill Green, and Ming Xu), synaptic, circuit and systems-level analyses (Dan McGehee, Mark Sheffield, Dan Margoliash, and Fred Garcia), human behavioral pharmacology, fMRI imaging and treatment (Harriet de Wit, Andrea King, Jon Grant, Dave Gallo, and Chin-tu Chen) and public health, epidemiology and policy (Don Hedeker, John Schneider, and Harold Pollack). Our training grant brings together faculty and trainees from different disciplines to exchange views and participate in professional development and outreach.   

 

The NIDA Training Program at the University of Chicago a lively cross-disciplinary intellectual environment that includes the Grossman Neuroscience Institute, Institute for Translational Medicine, human and animal behavioral laboratories, a drug abuse treatment program, and epidemiological and policy-related studies.   

 

Post-doctoral candidates should contact the faculty member with whom they wish to work http://voices.uchicago.edu/addictiont32/ or submit a cover letter and curriculum vitae to Elena Rizzo <erizzo@uchicago.edu>.  Appointments are usually for two years. Applicants must be US citizens or permanent residents. 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] POSTDOCTORAL POSITION AT UNIVERSITY OF KENTUCKY

Sending on behalf of Dr. Michael Bardo:

POSTDOCTORAL POSITION IN DRUG ABUSE RESEARCH:   We are seeking to fill 2-3 postdoctoral research positions that will investigate the (1) neurobehavioral, (2) functional, and (3) genomic mechanisms of opioid abuse using preclinical models and extending them to human genetic data.  This is part of a NIDA-funded MPI collaboration between Dr. Michael Bardo (Department of Psychology), Dr. Pavel Ortinski (Department of Neuroscience), and Dr. Jill Turner (Department of Pharmaceutical Sciences).  As such, individuals will work closely together on a transdisciplinary project with opportunities for dual training in neurobehavioral, electrophysiological and/or genomic approaches.  Primary opportunities in training include drug self-administration, chemogenetics, calcium imaging, slice electrophysiology, and single-cell RNA-Seq/ATAC-Seq.  We are especially interested in applicants who are willing to exchange ideas across interdisciplinary lines.  Applicants must have completed a PhD or equivalent degree in psychology, pharmacology, neuroscience, or related discipline.  Send curriculum vitae, brief cover letter stating preferred training interests, and at least two names with contact information of individuals who can provide a letter of recommendation to:  Dr. Michael Bardo (mbardo@uky.edu), University Research Professor, Department of Psychology, University of Kentucky, Lexington KY 40536-0509, USA.  The University of Kentucky is an Affirmative Action/Equal Opportunity Employer. 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] NIDA Neuroscience Update, March 4, 2021

Table of Contents

I.                   Job Opening (Formulation of Drug Product - Chemist) at NIDA Headquarters - Rockville, Maryland

II.                 NIDA Data Career Seminar Series

III.              Some Recent NIDA Funding Opportunities (FOAs)

 

I.               Job Opening (Formulation of Drug Product -  Chemist) at NIDA Headquarters - Rockville, Maryland

The Division of Therapeutics and Medical Consequences (DTMC) supports and conducts studies to evaluate the safety and efficacy of new pharmacotherapies, behavioral therapies, devices, and digital therapeutics to treat Substance Use Disorders (SUDs). DTMC supports research and development for all stages of the medication development process.

 

Chemistry and Pharmaceutics: The incumbent is responsible for managing a research program of grants and contracts evaluating chemical design, synthesis, formulation, metabolism, pharmacokinetic and pharmacodynamic, and biopharmaceutics.  While not exclusive to, the focus of this position is the formulation of drug products, which includes design, manufacturing, quality control, packaging, labeling, storage and stability.  If interested:  Please submit your cover letter, and CV to Dr. Rik Kline (rkline@nida.nih.gov) 301-827-5243.  All information provided by candidates will remain strictly confidential.  Selection for this position is dependent upon successful referral from the USAJOBS vacancy announcement (TBA).  A candidate with a Ph.D in a relevant discipline is strongly desired (salary range is between $86,335 to $157,709).

 

 

II.             NIDA Data Career Seminar Series

NIDA will be hosting a 4-part Data Science careers seminar series this spring titled Bringing Data Science to Addiction Research. The goal of this seminar series is to highlight the career paths of prominent data scientists and inspire a new generation of data science researchers who focus on addiction. This series will take place on the following dates from 9:00-10:30am EDT (Please note that this is during Daylights Savings Time): March 15th, March 22nd, March 29th, and April 5th. A separate registration will be required for each session.

Contact Dr. Susan Wright at susan.wright@nih.gov with any questions.

This series will kick off with a fireside chat with Dr. DJ Patil (Twitter: @dpatil), the former U.S. Chief Data Scientist, on March 15h from 9:00-10:30am EST. Register for this session at: https://bit.ly/3kEHw7c

 

III.            Recent NIDA FOAs:

 

Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorder Notice Number: NOT-DA-20-030     Application due date: Standard dates apply                                                                                                                                                   

High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) RFA-DA-22-006  Application due date: Standard dates apply                                                                                                                                                   

Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) RFA-DA-22-010 Application due dates: October 25, 2021 and October 25, 2022 by 5:00 PM local time of applicant organization.

 

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) PAR-20-225 (DP1) Application due dates: October 19, 2021, October 19, 2022 by 5:00 PM local time of applicant organization.

 

Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) PAR-20-224 (DP2)   Application due dates: August 13, 2020, August 13, 2021, August 15, 2022 by 5:00 PM local time of applicant organization.

 

Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)

RFA-DA-22-004 (R61/R33) Application due dates: July 14, 2021 and July 14, 2022 by 5:00 PM local time of applicant organization.

 

NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) RFA-DA-22-008 Application due date: September 15, 2021 by 5:00 PM local time of applicant organization.

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

[#DIV28M] Visiting Position in Psychology/Neuroscience at Earlham College (renewable up to 3 years)

Hi All,

We are searching for a Visiting Assistant Professor in Psychology who can contribute to the Neuroscience major. This position is renewable for up to 3 years. The job description can be found here and is pasted below.

Earlham College Department of Psychology invites applications for a full-time, Visiting Assistant Professor position with an ability to contribute to neuroscience. The position may be renewable up to three years. Start date is July 1, 2021.

Primary Duties & Responsibilities

The successful candidate will have a teaching load of 5 courses across two semesters. After the first year, the successful candidate will advise students in the neuroscience major. At Earlham, Visiting Faculty have access to the same professional development and summer research funding sources as tenure-track and tenured faculty. Earlham also seeks to cultivate faculty interests and the successful candidate will have opportunities to teach upper-level courses in their area of interest and will be well-prepared for the tenure-track job market at the conclusion of the visiting position.

In the cover letter, candidates should indicate their ability to teach neuroscience courses, such as Brain & Behavior, as well as other core psychology courses such as Introductory Psychology or Research Methods & Statistics. Candidates should also specify additional upper-level courses that they could teach that are not currently offered in the department. We are particularly interested in the breadth that candidates can bring to the psychology department and the neuroscience major. Opportunities to engage in research are available, but not required for visiting positions. These opportunities include paid summer research with undergraduate students and professional development funds. Candidates interested in pursuing research in this position are encouraged to indicate how they would involve undergraduates in research opportunities in the context of a small liberal arts school. In the application materials, candidates should clearly describe their ability to contribute to the advancement of Earlham's goals to be a diverse, equitable, and inclusive institution. Candidates should provide specific examples of how they have contributed to equitable and inclusive environments, including how they support students from diverse backgrounds and how they use inclusive pedagogical practices.

Departmental & Institutional Information

Earlham College is a small, private liberal arts college shaped by Quaker principles, including a commitment to social justice. The Earlham College student body is diverse (~20% international, ~25% domestic students of color) and there are multiple opportunities to work with students in meaningful ways both in and out of the classroom. Psychology and neuroscience are among the largest majors on campus. We strive to create a welcoming, inclusive environment where all community members can thrive. Earlham has family-friendly policies and the psychology department offers a structured mentorship program to support new faculty members.

Experience & Qualifications

Candidates should hold a Ph.D. in psychology, neuroscience, or a related field at the time of appointment. Candidates who are ABD ("All But Dissertation") and have finished their coursework and qualifying exams may be considered. Candidates with a degree other than neuroscience should clearly explain their expertise in neuroscience, which could include graduate coursework, research background, or teaching history. Candidates should have prior teaching experience and evidence of teaching effectiveness, which could include student evaluations, peer observations, or other similar evidence. Earlham College and the psychology department continue to build a community that reflects our student body and society at large. We encourage and welcome applications from members of groups historically underrepresented in higher education. Candidates who meet some, but not all of the desired qualities for this position are encouraged to apply. Candidates may also contact the search convener with specific questions.

Application Instructions

Applicants should send a single PDF including a

1. cover letter

2. curriculum vitae (including contact information for 3 references)

3. teaching statement 

4. evidence of teaching effectiveness

5. diversity statement

6. research statement (optional)

 

The Department will solicit letters of reference directly from listed references at its discretion.

 

Materials should be sent to neurosearch@earlham.edu.  

 

Review of applications will begin immediately and continue until the position is filled. Applications submitted by March 22, 2021 will be given full consideration. Any inquiries about the position can be directed to Dr. Beth Mechlin, Search Convener, mechlbe@earlham.edu. 

Earlham College is an Equal Opportunity Employer that seeks applications from candidates who contribute to diversity in terms of race, ethnicity, age, religious affiliation, gender, sexual orientation, gender identity, disability, and veteran status, among other distinctions and contributions. As a College with a Quaker identity, Earlham also is eager to solicit applications from members of the Religious Society of Friends (Quakers).

--

Beth Mechlin, Ph.D.
Associate Professor of Psychology and Neuroscience
Earlham College
801 National Road West, Box 28
Richmond, IN 47374
mechlbe@earlham.edu
she/her pronouns
765-983-1785
https://profbeth.youcanbook.me

Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congrats Bill! Much-deserved.

 

Please keep inspiring all of us with your energy, commitment and accomplishments in substance use research!

 

 

Nehal P. Vadhan, PhD

Associate Professor

Director, Human Neuropsychopharmacology Laboratory (HNPPL)

Associate Director, Center for Addiction Services and Personalized Interventions Research (CASPIR)

Senior Research Scientist, Wellbridge Center for Addiction Science

Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell

Feinstein Institute for Medical Research

E: nvadhan@northwell.edu  
P: 516-837-1685

 

https://feinstein.northwell.edu/institutes-researchers/our-researchers/nehal-p-vadhan-phd

https://www.northwell.edu/behavioral-health/programs-services/center-for-addiction-services-personalized-interventions-research

https://wellbridge.org/team/nehal-p-vadhan/

 

 

 

From: div28super reaches div28 and div28m and its nested lists (e.g. div28s) [mailto:DIV28SUPER@LISTS.APA.ORG] On Behalf Of Kelly Dunn
Sent: Thursday, February 25, 2021 4:00 PM
To: DIV28SUPER@LISTS.APA.ORG
Subject: [EXTERNAL] [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

 

External Email. Do not click links or open attachments unless you trust the sender and content. Report suspicious emails using Report Phishing button or forward email to phish@northwell.edu

Hello Div28 colleagues,

 

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

 

 

https://www.apa.org/about/governance/president/citation/william-stoops

 

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

 

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

 

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

 

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

 

 

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

 

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congrats, Bill! This is very impressive and well deserved.

 

From: "div28super reaches div28 and div28m and its nested lists (e.g. div28s)" <DIV28SUPER@LISTS.APA.ORG> on behalf of Kelly Dunn <kdunn9@JHMI.EDU>
Reply-To: Kelly Dunn <kdunn9@JHMI.EDU>
Date: Thursday, February 25, 2021 at 4:11 PM
To: "DIV28SUPER@LISTS.APA.ORG" <DIV28SUPER@LISTS.APA.ORG>
Subject: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

 

Hello Div28 colleagues,

 

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

 

 

https://www.apa.org/about/governance/president/citation/william-stoops

 

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

 

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

 

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

 

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

 

 

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

 

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congratulations Bill from one recent recipient of the award to another-

Clearly greatly deserved.

Martin

Be the light.

Sent from my iPhone

On Feb 25, 2021, at 1:12 PM, Kelly Dunn <kdunn9@jhmi.edu> wrote:



Hello Div28 colleagues,

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

https://www.apa.org/about/governance/president/citation/william-stoops

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28